Search

Your search keyword '"SOFFIETTI, RICCARDO"' showing total 1,181 results

Search Constraints

Start Over You searched for: Author "SOFFIETTI, RICCARDO" Remove constraint Author: "SOFFIETTI, RICCARDO"
1,181 results on '"SOFFIETTI, RICCARDO"'

Search Results

52. Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

53. Contributors List

56. European Cancer Organisation Essential Requirements for Quality Cancer Care: Adult glioma

59. The Evolving Landscape of Brain Metastasis

60. Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop.

61. Histology and Anatomic Site in Ependymoma

63. Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group

66. RTID-02. SILMET TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE SILIBININ IN PREVENTING INTRACRANIAL RECURRENCE AFTER COMPLETE RESECTION OF A SINGLE BRAIN METASTASIS FROM NSCLC OR BREAST CANCER

67. QOL-26. A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT IDH1/2DIFFUSE GLIOMA (INDIGO): ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE, NEUROCOGNITION AND SEIZURES

68. CTNI-51. A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT IDH1/2 DIFFUSE GLIOMA (INDIGO): EXPLORATORY ANALYSIS OF VARIANT ALLELE FREQUENCY AND PROGRESSION-FREE SURVIVAL

69. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

70. Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper

71. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

72. EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors

73. The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective.

78. STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis

81. Long-term survival with IDH wildtype glioblastoma: First results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419).

82. EANO guidelines for the diagnosis and treatment of meningiomas

85. European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)

86. Long-term survival with IDH wildtype glioblastoma:first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)

87. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)

88. The early recognition and diagnosis of neoplastic meningitis.

89. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology

90. Response assessment criteria for brain metastases: proposal from the RANO group

93. Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma

96. The 2022 European Postgraduate (Residency) Program in Neurology in an historical and international perspective

97. Ependymomas

Catalog

Books, media, physical & digital resources